Literature DB >> 12482200

Surface binding and uptake of heat shock protein 70 by antigen-presenting cells require all 3 domains of the molecule.

Christine Zimmer1, Tamás Henics.   

Abstract

The surprisingly efficient uptake of peptide-loaded heat shock proteins (Hsps) by antigen-presenting cells (APCs) has been recently associated with a specific receptor-ligand-based mechanism, and the identity of at least 1 receptor has been determined. In this study, we tested how the domain composition of the stress protein affected its surface association and internalization by APCs, and this was facilitated by the availability of the 70-kDa human heat shock protein (Hsp70) and its various deletion mutants. We show that both these processes strictly depend on the presence of all 3 domains of Hsp70. We propose that the previously described interdomain interactions as a determinant of a favorable conformational status might also govern a sterical adaptation of Hsps to components of the internalization machinery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482200      PMCID: PMC514824          DOI: 10.1379/1466-1268(2002)007<0243:sbauoh>2.0.co;2

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  20 in total

1.  CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin.

Authors:  S Basu; R J Binder; T Ramalingam; P K Srivastava
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

2.  Intragenic suppressors of Hsp70 mutants: interplay between the ATPase- and peptide-binding domains.

Authors:  J E Davis; C Voisine; E A Craig
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway.

Authors:  S Basu; R J Binder; R Suto; K M Anderson; P K Srivastava
Journal:  Int Immunol       Date:  2000-11       Impact factor: 4.823

4.  Cutting edge: heat shock protein gp96 induces maturation and migration of CD11c+ cells in vivo.

Authors:  R J Binder; K M Anderson; S Basu; P K Srivastava
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

Review 5.  Immunotherapy of human cancer: lessons from mice.

Authors:  P K Srivastava
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

6.  Saturation, competition, and specificity in interaction of heat shock proteins (hsp) gp96, hsp90, and hsp70 with CD11b+ cells.

Authors:  R J Binder; M L Harris; A Ménoret; P K Srivastava
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

7.  CD91: a receptor for heat shock protein gp96.

Authors:  R J Binder; D K Han; P K Srivastava
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

8.  Characterization of a receptor for heat shock protein 70 on macrophages and monocytes.

Authors:  H Sondermann; T Becker; M Mayhew; F Wieland; F U Hartl
Journal:  Biol Chem       Date:  2000-12       Impact factor: 3.915

9.  Analysis of sequence-specific binding of RNA to Hsp70 and its various homologs indicates the involvement of N- and C-terminal interactions.

Authors:  C Zimmer; A von Gabain; T Henics
Journal:  RNA       Date:  2001-11       Impact factor: 4.942

10.  Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways.

Authors:  F Castellino; P E Boucher; K Eichelberg; M Mayhew; J E Rothman; A N Houghton; R N Germain
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  1 in total

1.  Gene expression and functional studies of small heat shock protein 37 (MrHSP37) from Macrobrachium rosenbergii challenged with infectious hypodermal and hematopoietic necrosis virus (IHHNV).

Authors:  Jesu Arockiaraj; Puganeshwaran Vanaraja; Sarasvathi Easwvaran; Arun Singh; Rofina Yasmin Othman; Subha Bhassu
Journal:  Mol Biol Rep       Date:  2012-06       Impact factor: 2.316

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.